Vildagliptin Versus Glimepiride in Type 2 Diabetic Patients
NCT06068686
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
70
Enrollment
OTHER
Sponsor class
Conditions
Type 2 Diabetes
Interventions
DRUG:
Vildagliptin 50 MG
DRUG:
Glimepiride 3 Mg Oral Tablet
Sponsor
Damanhour University